Jane Street
MBOT icon

Jane Street’s Microbot Medical MBOT Stock Holding History

Jane Street’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,600
Closed -$40K – 12500
2026
Q1 		$40K Buy
16,600
+5,300
+47% +$11.8K ﹤0.01% 11039
2025
Q4 		$22.6K Sell
11,300
-5,200
-32% -$12.3K ﹤0.01% 10700
2025
Q3 		$50.3K Buy
+16,500
New +$51.5K ﹤0.01% 10351

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $38B AUM 25.01% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Jane Street's MBOT Position: Q3 2026 in Review

Jane Street reduced its Microbot Medical (MBOT) stake by 59% in Q3 2026, selling an estimated $101K and leaving 43,232 shares worth $51.9K. The position accounts for ﹤0.01% of the portfolio, ranked #10951.

Jane Street first reported a position in MBOT in Q1 2014 and has held it in 9 quarters since. The position peaked at $591K in Q3 2025. 61 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.

  • Jane Street held 43,232 shares of Microbot Medical worth $51.9K as of Q3 2026.
  • Jane Street sold 62,902 Microbot Medical shares in Q3 2026, an estimated $101K.
  • Microbot Medical made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #10951 holding.
  • Jane Street first reported a position in Microbot Medical in Q1 2014 and has held it in 9 quarters since.
  • Jane Street's Microbot Medical position peaked at $591K in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.